Home
Epigral Ltd Share Price History
Epigral Ltd
NSE : 23 May, 2025
1858.8-12.2 (-0.7%)
Prev Close
1871.0
Open Price
1876.0
Bid Price (QTY)
-
Offer Price (QTY)
-
Volume
20039
Today's High / Low
1877.5 / 1840.1
52 WK High / Low
2406.8 / 1110.1
Market Price of Epigral Ltd
1M
1Y
3Y
5Y
Monitoring Epigral Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
History Market Price
| Date | Price | Open | High | Low |
|---|
Returns Comparison
1W
1M
3M
6M
1Y
3Y
5Y
10Y
Growth Parameters
| Parameter |  2021 |
|---|---|
| Sales (Cr.) | NaN |
| Sales YoY Gr. | - |
| Adj EPS | 24.27 |
| YoY Gr. | - |
| Net Profit (Cr.) | 101 |
| BVPS | 113.88 |
Key Financial Parameters
| Parameter | 2021 |
|---|---|
| Return on Capital Emp. % | 15.47 |
| Op. Profit Mgn % | 31.8 |
| Net Profit Mgn % | 12.17 |
| Debt to Equity % | 0.79 |
Latest Shareholding
Promoters Holdings Over Time
About Epigral Ltd
- Epigral Limited was erstwhile incorporated as Meghmani Finechem Limited in 2007, which engaged in manufacturing and selling of Chlor Alkali & its Derivatives and also in Trading of Agrochemical products.
- The Company was incorporated as a subsidiary of Meghmani Organics Limited. Meghmani Finechem Limited (MFL) was demerged from Meghmani Organics Limited (MOL) as a going concern through the Scheme of Arrangement for Demerger and the said Scheme became effective from May 10, 2021.
- The Chlor-Alkali business commissioned in 2009, growing from an installed capacity of 1,88,000 TPA in 2015 to 3,15,000 TPA at the close of FY 2020-21.
- The Company is now among the leading players in India's chlor alkali industry.
- In terms of the said Scheme, the Company allotted 2,39,03,029 Equity Shares of Rs 10/- each on 20th May, 2021 to the shareholders of Meghmani Organics Limited.
Popular Search
FAQs for Epigral Ltd Share Price History
What are the key events that typically impact Epigral Ltd's share price history?
Key events that impact Epigral Ltd’s share price history include quarterly earnings releases, product launches, leadership changes, economic policies, and geopolitical developments.
How do stock splits affect Epigral Ltd's share price history?
Stock splits reduce the nominal price of Epigral Ltd's shares by increasing the number of outstanding shares, which typically makes the stock more accessible to a broader range of investors. Although the total market value of the company remains unchanged after the split, the split can affect investor perception and liquidity, potentially influencing the share price in the longer term.
How do dividends impact the share price history of Epigral Ltd?
Dividends can influence Epigral Ltd's share price history by typically causing a temporary dip on the ex-dividend date, as the stock price often adjusts to reflect the dividend payout. Over time, the impact of dividends on the share price may be offset by the company's overall financial performance and market conditions.
How do corporate announcements affect Epigral Ltd’s share price history?
Corporate announcements such as mergers, acquisitions, or strategic shifts can lead to significant price changes. Any optimistic development news on Epigral Ltd generally boosts the company’s share price, whereas negative news can lead to a decline in share price.
How can I use technical analysis to understand Epigral Ltd’s share price history?
To understand Epigral Ltd’s share price history using technical analysis, examine charts for patterns such as trends, support, and resistance levels, and apply indicators like moving averages or Relative Strength Index (RSI) to gauge potential future movements. Analyze historical data to identify recurring trends and signals that might suggest how the share price could behave under similar conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
